Education
About Us
Working with TipRanks
Follow Us
Marcus Schabacker Insider Profile
4 Followers
Marcus Schabacker, CVP, Chief Scientific Officer at Baxter International, holds 48.05K shares in Enveric Biosciences (Ticker: ENVB), holds 29.96K shares in Baxter International (Ticker: BAX).
Marcus Schabacker has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Marcus Schabacker holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Marcus Schabacker
Marcus Schabacker's Trading History
Baxter International
Mar 08, 2017
CVP, Chief Scientific Officer
Uninformative Sell
14.49K
$1.10M
Enveric Biosciences
Oct 11, 2024
Director
Uninformative Buy
―
$87.46K
List of latest transactions for each holding click on a transaction to see Marcus Schabacker's performance on stock
You May Also Like
Marcus Schabacker insider profile FAQ
What is the percentage of profitable transactions made by Marcus Schabacker?
The percentage of profitable transactions made by Marcus Schabacker is ―.
What is the average return per transaction made by Marcus Schabacker?
The average return per transaction made by Marcus Schabacker is ―.
What stocks does Marcus Schabacker hold?
Marcus Schabacker holds: BAX, ENVB stocks.
What was Marcus Schabacker’s latest transaction?
Marcus Schabacker latest transaction was an Uninformative Buy of ―.
What was Marcus Schabacker's most profitable transaction?
Marcus Schabacker’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Marcus Schabacker's role in Baxter International?
Marcus Schabacker's role in Baxter International is CVP, Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.